Cell Separation and Characterization in Solid Tumors Market - Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: C407F20779ADEN
Market Monitor Global

Abstracts

Solid tumors are abnormal mass of tissue that usually does not contain cysts or liquid areas.

This report contains market size and forecasts of Cell Separation and Characterization in Solid Tumors in Global, including the following market information:

Global Cell Separation and Characterization in Solid Tumors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cell Separation and Characterization in Solid Tumors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Fluorescence-Activated Cell Sorting Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cell Separation and Characterization in Solid Tumors include AbbVie, Abcodia, AstraZeneca, Illumina, Merck, Miltenyi Biotech, Pfizer and Thermo Fisher Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell Separation and Characterization in Solid Tumors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cell Separation and Characterization in Solid Tumors Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cell Separation and Characterization in Solid Tumors Market Segment Percentages, by Type, 2021 (%)

• Fluorescence-Activated Cell Sorting
• Magnet-Activated Cell Sorting
• Density Gradient Centrifugation
• Dielectrophoretic
• Aqueous Two-Phase System
• Field Flow Fractionation

Global Cell Separation and Characterization in Solid Tumors Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cell Separation and Characterization in Solid Tumors Market Segment Percentages, by Application, 2021 (%)

• Diagnostics and Testing Laboratories
• Academic and Research Organizations
• Others

Global Cell Separation and Characterization in Solid Tumors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cell Separation and Characterization in Solid Tumors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cell Separation and Characterization in Solid Tumors revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cell Separation and Characterization in Solid Tumors revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Abcodia
• AstraZeneca
• Illumina
• Merck
• Miltenyi Biotech
• Pfizer
• Thermo Fisher Scientific

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cell Separation and Characterization in Solid Tumors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cell Separation and Characterization in Solid Tumors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CELL SEPARATION AND CHARACTERIZATION IN SOLID TUMORS OVERALL MARKET SIZE

2.1 Global Cell Separation and Characterization in Solid Tumors Market Size: 2021 VS 2028
2.2 Global Cell Separation and Characterization in Solid Tumors Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cell Separation and Characterization in Solid Tumors Players in Global Market
3.2 Top Global Cell Separation and Characterization in Solid Tumors Companies Ranked by Revenue
3.3 Global Cell Separation and Characterization in Solid Tumors Revenue by Companies
3.4 Top 3 and Top 5 Cell Separation and Characterization in Solid Tumors Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cell Separation and Characterization in Solid Tumors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Separation and Characterization in Solid Tumors Players in Global Market
  3.6.1 List of Global Tier 1 Cell Separation and Characterization in Solid Tumors Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cell Separation and Characterization in Solid Tumors Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cell Separation and Characterization in Solid Tumors Market Size Markets, 2021 & 2028
  4.1.2 Fluorescence-Activated Cell Sorting
  4.1.3 Magnet-Activated Cell Sorting
  4.1.4 Density Gradient Centrifugation
  4.1.5 Dielectrophoretic
  4.1.6 Aqueous Two-Phase System
  4.1.7 Field Flow Fractionation
4.2 By Type - Global Cell Separation and Characterization in Solid Tumors Revenue & Forecasts
  4.2.1 By Type - Global Cell Separation and Characterization in Solid Tumors Revenue, 2017-2022
  4.2.2 By Type - Global Cell Separation and Characterization in Solid Tumors Revenue, 2023-2028
  4.2.3 By Type - Global Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cell Separation and Characterization in Solid Tumors Market Size, 2021 & 2028
  5.1.2 Diagnostics and Testing Laboratories
  5.1.3 Academic and Research Organizations
  5.1.4 Others
5.2 By Application - Global Cell Separation and Characterization in Solid Tumors Revenue & Forecasts
  5.2.1 By Application - Global Cell Separation and Characterization in Solid Tumors Revenue, 2017-2022
  5.2.2 By Application - Global Cell Separation and Characterization in Solid Tumors Revenue, 2023-2028
  5.2.3 By Application - Global Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cell Separation and Characterization in Solid Tumors Market Size, 2021 & 2028
6.2 By Region - Global Cell Separation and Characterization in Solid Tumors Revenue & Forecasts
  6.2.1 By Region - Global Cell Separation and Characterization in Solid Tumors Revenue, 2017-2022
  6.2.2 By Region - Global Cell Separation and Characterization in Solid Tumors Revenue, 2023-2028
  6.2.3 By Region - Global Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cell Separation and Characterization in Solid Tumors Revenue, 2017-2028
  6.3.2 US Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.3.3 Canada Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.3.4 Mexico Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cell Separation and Characterization in Solid Tumors Revenue, 2017-2028
  6.4.2 Germany Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.4.3 France Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.4.4 U.K. Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.4.5 Italy Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.4.6 Russia Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.4.7 Nordic Countries Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.4.8 Benelux Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cell Separation and Characterization in Solid Tumors Revenue, 2017-2028
  6.5.2 China Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.5.3 Japan Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.5.4 South Korea Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.5.5 Southeast Asia Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.5.6 India Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cell Separation and Characterization in Solid Tumors Revenue, 2017-2028
  6.6.2 Brazil Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.6.3 Argentina Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cell Separation and Characterization in Solid Tumors Revenue, 2017-2028
  6.7.2 Turkey Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.7.3 Israel Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.7.4 Saudi Arabia Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028
  6.7.5 UAE Cell Separation and Characterization in Solid Tumors Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Cell Separation and Characterization in Solid Tumors Major Product Offerings
  7.1.4 AbbVie Cell Separation and Characterization in Solid Tumors Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Abcodia
  7.2.1 Abcodia Corporate Summary
  7.2.2 Abcodia Business Overview
  7.2.3 Abcodia Cell Separation and Characterization in Solid Tumors Major Product Offerings
  7.2.4 Abcodia Cell Separation and Characterization in Solid Tumors Revenue in Global Market (2017-2022)
  7.2.5 Abcodia Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Cell Separation and Characterization in Solid Tumors Major Product Offerings
  7.3.4 AstraZeneca Cell Separation and Characterization in Solid Tumors Revenue in Global Market (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 Illumina
  7.4.1 Illumina Corporate Summary
  7.4.2 Illumina Business Overview
  7.4.3 Illumina Cell Separation and Characterization in Solid Tumors Major Product Offerings
  7.4.4 Illumina Cell Separation and Characterization in Solid Tumors Revenue in Global Market (2017-2022)
  7.4.5 Illumina Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Cell Separation and Characterization in Solid Tumors Major Product Offerings
  7.5.4 Merck Cell Separation and Characterization in Solid Tumors Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Miltenyi Biotech
  7.6.1 Miltenyi Biotech Corporate Summary
  7.6.2 Miltenyi Biotech Business Overview
  7.6.3 Miltenyi Biotech Cell Separation and Characterization in Solid Tumors Major Product Offerings
  7.6.4 Miltenyi Biotech Cell Separation and Characterization in Solid Tumors Revenue in Global Market (2017-2022)
  7.6.5 Miltenyi Biotech Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Cell Separation and Characterization in Solid Tumors Major Product Offerings
  7.7.4 Pfizer Cell Separation and Characterization in Solid Tumors Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Key News
7.8 Thermo Fisher Scientific
  7.8.1 Thermo Fisher Scientific Corporate Summary
  7.8.2 Thermo Fisher Scientific Business Overview
  7.8.3 Thermo Fisher Scientific Cell Separation and Characterization in Solid Tumors Major Product Offerings
  7.8.4 Thermo Fisher Scientific Cell Separation and Characterization in Solid Tumors Revenue in Global Market (2017-2022)
  7.8.5 Thermo Fisher Scientific Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cell Separation and Characterization in Solid Tumors Market Opportunities & Trends in Global Market
Table 2. Cell Separation and Characterization in Solid Tumors Market Drivers in Global Market
Table 3. Cell Separation and Characterization in Solid Tumors Market Restraints in Global Market
Table 4. Key Players of Cell Separation and Characterization in Solid Tumors in Global Market
Table 5. Top Cell Separation and Characterization in Solid Tumors Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cell Separation and Characterization in Solid Tumors Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cell Separation and Characterization in Solid Tumors Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cell Separation and Characterization in Solid Tumors Product Type
Table 9. List of Global Tier 1 Cell Separation and Characterization in Solid Tumors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell Separation and Characterization in Solid Tumors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cell Separation and Characterization in Solid Tumors Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cell Separation and Characterization in Solid Tumors Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cell Separation and Characterization in Solid Tumors Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cell Separation and Characterization in Solid Tumors Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cell Separation and Characterization in Solid Tumors Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cell Separation and Characterization in Solid Tumors Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Cell Separation and Characterization in Solid Tumors Product Offerings
Table 32. AbbVie Cell Separation and Characterization in Solid Tumors Revenue (US$, Mn), (2017-2022)
Table 33. Abcodia Corporate Summary
Table 34. Abcodia Cell Separation and Characterization in Solid Tumors Product Offerings
Table 35. Abcodia Cell Separation and Characterization in Solid Tumors Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Cell Separation and Characterization in Solid Tumors Product Offerings
Table 38. AstraZeneca Cell Separation and Characterization in Solid Tumors Revenue (US$, Mn), (2017-2022)
Table 39. Illumina Corporate Summary
Table 40. Illumina Cell Separation and Characterization in Solid Tumors Product Offerings
Table 41. Illumina Cell Separation and Characterization in Solid Tumors Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Cell Separation and Characterization in Solid Tumors Product Offerings
Table 44. Merck Cell Separation and Characterization in Solid Tumors Revenue (US$, Mn), (2017-2022)
Table 45. Miltenyi Biotech Corporate Summary
Table 46. Miltenyi Biotech Cell Separation and Characterization in Solid Tumors Product Offerings
Table 47. Miltenyi Biotech Cell Separation and Characterization in Solid Tumors Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Cell Separation and Characterization in Solid Tumors Product Offerings
Table 50. Pfizer Cell Separation and Characterization in Solid Tumors Revenue (US$, Mn), (2017-2022)
Table 51. Thermo Fisher Scientific Corporate Summary
Table 52. Thermo Fisher Scientific Cell Separation and Characterization in Solid Tumors Product Offerings
Table 53. Thermo Fisher Scientific Cell Separation and Characterization in Solid Tumors Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cell Separation and Characterization in Solid Tumors Segment by Type in 2021
Figure 2. Cell Separation and Characterization in Solid Tumors Segment by Application in 2021
Figure 3. Global Cell Separation and Characterization in Solid Tumors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell Separation and Characterization in Solid Tumors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell Separation and Characterization in Solid Tumors Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell Separation and Characterization in Solid Tumors Revenue in 2021
Figure 8. By Type - Global Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028
Figure 12. US Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028
Figure 16. Germany Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 17. France Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028
Figure 24. China Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 28. India Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028
Figure 30. Brazil Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cell Separation and Characterization in Solid Tumors Revenue Market Share, 2017-2028
Figure 33. Turkey Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cell Separation and Characterization in Solid Tumors Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Cell Separation and Characterization in Solid Tumors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abcodia Cell Separation and Characterization in Solid Tumors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca Cell Separation and Characterization in Solid Tumors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Illumina Cell Separation and Characterization in Solid Tumors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Cell Separation and Characterization in Solid Tumors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Miltenyi Biotech Cell Separation and Characterization in Solid Tumors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Cell Separation and Characterization in Solid Tumors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Thermo Fisher Scientific Cell Separation and Characterization in Solid Tumors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)